About OFEV

OFEV is a prescription medication containing the active ingredient Nintedanib (Nintedanib esilate), a tyrosine kinase inhibitor. It is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease characterized by scarring of the lung tissue.

Key Benefits & Uses

Treatment of idiopathic pulmonary fibrosis (IPF) to slow down disease progression and improve lung function.
Slowing the rate of decline in lung function in patients with IPF.
Improvement in symptoms and quality of life in patients with IPF.

Active Ingredient & Action

Nintedanib (Nintedanib esilate) works by inhibiting the activity of certain enzymes, known as tyrosine kinases, which play a role in the growth and spread of fibrotic tissue in the lungs. By blocking these enzymes, Nintedanib helps to slow down the progression of IPF and improve lung function.

Important Notes

OFEV should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of side effects. Patients with certain medical conditions, such as liver or kidney disease, should use OFEV with caution and under close medical supervision.